Product Specification
Alternative Name: | Apo-3L, TNFSF 12 |
|
Host: | Rabbit |
|
Immunogen: | Recombinant human TWEAK extracellular domain (aa 106-249) (Prod. No. ALX-522-021). |
|
UniProt ID: | Q9NS68 |
|
Source: | Purified from rabbit serum. |
|
Species reactivity: | Human, Mouse
|
|
Applications: | Flow Cytometry, IP, WB
|
|
Recommended Dilutions/Conditions: | Immunoprecipitation (1:100) Flow Cytometry (1:1,000) Western Blot (1:1,000) Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |
|
Purity Detail: | Epitope-affinity purified. |
|
Formulation: | Liquid. In PBS containing 0.02% sodium azide. |
|
Use/Stability: | Stable for at least 1 year after receipt when stored at -20°C. |
|
Handling: | Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -20°C. |
|
Shipping: | Shipped on Blue Ice |
|
Short Term Storage: | +4°C |
|
Long Term Storage: | -20°C |
|
Regulatory Status: | RUO - Research Use Only |
|
Product Literature References
CD163 interacts with TWEAK to regulate tissue regeneration after ischaemic injury: H. Akahori, et al.; Nat. Commun.
6, 7792 (2015),
Application(s): Serum immunoprecipitation,
Abstract;
General Literature References
TWEAK and Fn14: New molecular targets for cancer therapy?: J.A. Winkles, et al.; Cancer Lett.
235, 11 (2006),
Abstract;
TWEAK induces liver progenitor cell proliferation: A. Jakubowski, et al.; J. Clin. Invest.
115, 2330 (2005),
Abstract;
Full Text
Related Products